Contents

Every medical device sold in Australia sits on a paper trail that runs from the TGA’s Australian Register of Therapeutic Goods down through distributors, hospitals, retailers and end users. The insurance behind it has to match every link in that chain.

Medical device liability insurance is often mistaken for a single off-the-shelf product liability policy. It isn’t. It’s a layered placement covering product liability, public liability, professional indemnity and often product recall, structured to match the TGA classification, the ARTG sponsor role, and the actual work the business does. Get the structure wrong and the claim can fall into a gap that isn’t covered.

According to the Therapeutic Goods Administration, medical devices in Australia range from simple bandages through to Class III implantable cardiac devices, with software as a medical device (SaMD) now regulated explicitly alongside physical hardware. The regulatory framework is detailed and well understood. The insurance side, particularly for importers, scale-ups and software developers, is where businesses most often discover their cover doesn’t actually respond.

Medical Device Insurance in Australia - Key Checkpoints

  • TGA classification - Class I, IIa, IIb, III or AIMD determines the risk profile
  • ARTG listing - sponsor role carries product liability exposure
  • Essential Principles - compliance is an underwriting input, not a substitute for cover
  • Post-market surveillance - adverse event reporting interacts with notification clauses
  • Recall interaction - product liability and product recall are separate policies

Key Takeaways:

  • Medical device liability insurance is a stack of product liability, public liability and professional indemnity cover, not a single policy
  • TGA classification (Class I through III and SaMD) is the starting point underwriters use to price and scope cover
  • Standard product liability policies often exclude higher risk devices, implantables and software as a medical device
  • Importers and ARTG sponsors carry the same product liability exposure as the overseas manufacturer in Australia
  • Limits up to $20 million have been placed through specialist life sciences markets for businesses outside mainstream appetite

What is medical device liability insurance?

Medical device liability insurance is specialist cover taken out by businesses that manufacture, import, distribute, hire out or develop medical devices regulated by the TGA. It combines product liability on the device itself, public liability for general business operations, professional indemnity for advisory and software work, and in most life sciences programmes, a product recall section to respond when a device needs to be withdrawn from the market.

It’s a different animal to a generic small business liability policy. Once a product is a “medical device” under the Therapeutic Goods Act 1989, standard commercial policies either exclude it outright or respond with narrow wordings that don’t match the actual exposure. That includes the interaction with the TGA’s Essential Principles, the sponsor’s obligations once a device is listed on the ARTG, and post-market surveillance duties that continue for the life of the device.

A general business pack won’t cover an ARTG-listed medical device. A standard product liability policy often excludes Class IIb and III devices. And a tech company’s professional indemnity policy typically won’t respond to SaMD exposures without an explicit extension. This is a placement that needs to be built, not bought off a shelf.

Who needs medical device liability insurance in Australia?

The short answer is every link in the chain. In practice that means the Australian sponsor listed on the ARTG, the overseas manufacturer (where contractually exposed), importers and distributors, hospitals and clinics using the device, and software developers building regulated digital products.

ARTG sponsors and Australian manufacturers

The sponsor is the legal entity listed on the ARTG for a given device. That’s the business the TGA looks to for compliance, post-market surveillance and recall responsibility. It’s also the business that’s first in the firing line for product liability claims in Australia, regardless of who physically made the device. Local manufacturers and sponsors typically need combined public and product liability cover scaled to turnover, target markets and device class.

A Sydney importer of silicone and stainless steel children’s mealtime products came to Tank after the main insurance market panel declined the risk on the combination of children’s products and consumer chemicals exposure. We placed $20 million in public and product liability through specialist markets, compliant with Australian mandatory safety standards. The children’s products importer case study walks through how the placement was structured.

Importers and distributors

Importing a finished device into Australia exposes the importer to the same product liability regime as if they manufactured it locally. The Australian Consumer Law applies to safety defect claims, and the sponsor role under the Therapeutic Goods Act sits alongside it. Distributors moving devices between businesses carry their own layer of exposure, particularly around warehousing, labelling and supply chain documentation. Both typically need product liability cover that responds in Australian and sometimes worldwide jurisdiction.

Hire and clinical service businesses

Some businesses don’t manufacture or import - they hire devices to hospitals, clinics or end consumers. That sits in an awkward gap between product hire, clinical services and equipment rental. A therapeutic device hire business serving a maternity support clinical pathway came to Tank after multiple standard insurers declined on occupation alone. The therapeutic device hire case study explains how public liability and product liability were placed on low-voltage therapeutic devices hired to consumers.

SaMD and digital health developers

Software as a medical device (SaMD) is now explicitly regulated by the TGA, with clarity built up over recent years around AI-enabled diagnostic tools, clinical decision support software and therapeutic apps. The insurance for SaMD is where things get messy. Product liability wordings were largely drafted for physical products. Professional indemnity wordings were drafted for advice, not regulated products. A properly structured SaMD placement typically blends product liability (treating the software as a regulated device), technology E&O or professional indemnity for the development work, and cyber liability for data handling.

R&D consultancies and design houses

Businesses that don’t make the device themselves but do the research, design or data work behind it also carry exposure. Tank has placed cover for a biomedical engineering consultancy and a scientific data consultancy supporting life sciences clients. The exposure is usually more weighted to professional indemnity than product liability, but the lines blur once the consultancy’s work becomes part of a regulated device.

How does TGA classification affect insurance?

Every medical device in Australia is classified by risk, and that classification is the starting point underwriters use to price and scope cover.

Class Risk level Typical examples Insurance market
Class I Low Non-sterile bandages, stethoscopes, reusable surgical instruments Mainstream with extensions
Class IIa Low to medium Hearing aids, dental fillings, ultrasound imaging Mainstream or specialist
Class IIb Medium to high Ventilators, infusion pumps, some therapeutic lasers Specialist life sciences
Class III / AIMD High Implantable cardiac devices, neurological implants, breast implants Specialist only, higher limits
SaMD Varies by intended use AI diagnostic software, clinical decision support, therapeutic apps Specialist with blended wordings

Class I devices usually sit comfortably in mainstream product liability markets, particularly for small importers and distributors of non-sterile, non-invasive products. Class IIa often sits in the same markets but with tighter questions on manufacturing controls and post-market surveillance. Class IIb and Class III are almost always specialist placements, and the premium curve steepens materially at each step up.

SaMD doesn’t slot neatly into any of these bands. Pricing reflects the clinical risk of the underlying use case, the AI or algorithmic components, the data sources and whether the product is sold directly to clinicians, health services or consumers. For more on how early-stage chemical and consumer product makers are placed when standard markets decline, the baby skincare product liability case study shows the specialist market route.

What does a medical device liability policy actually cover?

A properly structured placement for a TGA-regulated device business usually includes several sections that have to be read together.

  • Public liability - third party injury or property damage arising from general business activities, including at trade shows, demonstrations, clinical sites and customer premises
  • Product liability - injury or property damage caused by the device itself, including failure modes, labelling errors, manufacturing defects and design failures
  • Professional indemnity / technology E&O - advice-based exposures for consultants, SaMD developers and R&D businesses, including algorithmic errors, software defects and clinical recommendations
  • Product recall - the sponsor’s own costs of withdrawing a device from the market under a TGA or voluntary recall, covered separately from product liability
  • Medical malpractice interaction - where clinicians use the device, the medical malpractice cover on the clinical side needs to dovetail with the device liability cover, not overlap or gap

Specialist life sciences policies from underwriters like Keystone Underwriting, SURA Life Sciences, Australasia Underwriting, Berkley, CFC and various Lloyd’s syndicates tend to bundle these sections into a single programme with consistent definitions and aggregates. Piecing the same cover together from standalone retail policies is possible but rarely as clean.

Does product liability cover software as a medical device?

Usually not in a clean way, no. Most standard product liability wordings were drafted with physical products in mind. SaMD sits in a grey zone where:

  • Product liability may respond to bodily injury caused by a software-driven recommendation, but often excludes “pure financial loss” or non-bodily consequences
  • Professional indemnity may respond to advice or design errors, but the software itself as a regulated product sits outside the typical PI trigger
  • Technology errors and omissions wordings come closer to the mark but weren’t drafted for therapeutic goods
  • Cyber liability handles the data side but not the clinical risk

A well structured SaMD placement explicitly blends these sections, typically through a specialist life sciences underwriter who understands the device classification and a technology market that understands the software. The documentation for that placement usually needs to show the ARTG inclusion or classification documentation, the intended use statement, clinical evaluation documentation and, where relevant, the algorithm validation approach.

How do recall and product liability interact?

Product liability and product recall are two different policies that trigger on two different events, and most businesses need both. The sibling guide on product recall insurance in Australia covers the recall side in detail, but the short version for device businesses is:

  • A product liability claim is brought by a patient, clinician or institution who’s been injured or whose property has been damaged by the device. The policy pays their claim plus legal defence
  • A product recall is an action the sponsor takes (or is directed to take) to withdraw the device under the TGA’s Procedure for Recalls, Product Alerts and Product Corrections (PRAC). The recall policy pays the sponsor’s own cost of doing that - notifications, logistics, disposal, business interruption

A single defect event can trigger both policies. A batch failure leads to patient injury (product liability claim) and a TGA-directed recall (recall claim). If only one policy is in place, only half the exposure is covered.

What coverage gaps do device businesses most often miss?

Recurring gaps worth pressure-testing before renewal.

Territorial scope, especially the United States

An Australian importer supplying a device domestically has different exposure to a local manufacturer shipping to the United States. US claims are a materially different risk and are usually excluded or priced separately. Any business with FDA plans, distribution in North America, or even online consumer sales that reach US customers should flag this specifically at placement.

Software updates and over-the-air changes

Modern devices, particularly with SaMD and connected hardware, receive software updates over the life of the product. Some wordings treat an updated product as a new product, resetting coverage triggers. Others don’t. For SaMD products shipping regular releases, this is worth getting in writing.

Clinical trial and investigational use

If a device is being supplied into a clinical trial before ARTG listing, standard product liability usually won’t respond. A clinical trials extension or standalone cover is needed. The clinical trials insurance guide covers this in detail.

Post-market surveillance and adverse event reporting

Post-market surveillance obligations don’t stop once the device is on the ARTG. Adverse events reported to the TGA can flow into notification obligations under the insurance policy. A late notification can prejudice coverage. Getting a clear process for adverse event reporting and insurer notification at placement avoids disputes at claim time.

CMO and contract manufacturer gaps

Most sponsors use a contract manufacturer. Responsibility for product defects at the CMO level often sits outside the sponsor’s cover, depending on the supply agreement. Whether the sponsor is named on the CMO’s policy, or whether the sponsor’s own cover responds to CMO-caused defects, is the question to ask explicitly.

How much does medical device liability insurance cost in Australia?

There isn’t a flat rate. Premium for a medical device business reflects:

  • TGA classification - Class I and IIa sit materially lower than Class IIb, III and AIMD
  • Turnover and distribution - annual revenue and where the product is sold, including any US exposure
  • Sponsor experience - first-time sponsors usually price higher than established businesses with a clean track record
  • Claims history - prior recalls, adverse events and product liability claims all flow into pricing
  • Limits required - $5M, $10M, $20M and beyond are achievable through specialist markets
  • SaMD complexity - algorithmic risk, AI components, intended use and data exposure all shift the number

For small importers and distributors of Class I and IIa devices, combined public and product liability premiums often start from a few thousand dollars per year. Class IIb, Class III, AIMD and complex SaMD products typically sit materially higher, with specialist wordings and layered programmes. Tank has placed up to $20 million in public and product liability through specialist life sciences markets where mainstream insurers have declined.

We don’t publish indicative premiums because the range is too wide to be useful. Give us the TGA classification, the product description, annual turnover and target markets and we’ll get you a realistic indication quickly.

How Tank Insurance can help

Tank Insurance specialises in placing life sciences insurance for Australian businesses that sit outside standard market appetite. That includes biotech scale-ups, ARTG sponsors, medical device manufacturers and importers, therapeutic device hire businesses, SaMD developers, and R&D consultancies working in the life sciences space.

We’ve placed cover across a range of life sciences risks including biomedical R&D consultancies, scientific research and data consultancies, therapeutic medical device distribution and hire, dermatologically tested consumer products, and imported children’s products. On the product liability side we’ve reached limits of $20 million through specialist markets for businesses the mainstream panel had declined on occupation or exposure.

Markets we place through on life sciences risks include specialist underwriters like Keystone Underwriting, SURA Life Sciences, Australasia Underwriting, Berkley, CFC and various Lloyd’s syndicates. These markets understand medical device classification, SaMD, post-market surveillance, clinical trial interaction and the Australian regulatory framework in a way that mainstream policies typically aren’t drafted to address.

If you’re building a device business, preparing an ARTG application, shipping a SaMD product into clinical use, or reviewing your existing cover against a new product line, it’s worth a conversation early. The sibling pieces on clinical trials insurance and product recall insurance cover the adjacent exposures most life sciences businesses also carry, and the professional indemnity and public liability pages cover the underlying product lines. For device use in clinical settings, the medical malpractice side usually needs to dovetail too.

Call us on 02 9000 1155 or email [email protected].

Frequently Asked Questions

What is medical device liability insurance in Australia?

Medical device liability insurance is a combination of product liability, public liability and often professional indemnity cover arranged for businesses that manufacture, import, distribute, hire out or develop medical devices regulated by the TGA. It responds to third party injury or property damage claims caused by the device, legal defence costs, and in some structures, professional advice exposures tied to device use or software development.

Do you need insurance to sell medical devices in Australia?

Insurance isn’t a single statutory requirement to list a device on the ARTG, but product liability cover is effectively mandatory in practice. Distributors, hospital procurement, private health funds and retailers almost always require a certificate of currency before agreeing to stock or use a device. For higher risk classes and software as a medical device, standard product liability policies usually won’t respond, and a specialist life sciences placement is needed.

How does TGA classification affect medical device insurance?

The TGA classifies medical devices from Class I (lowest risk) through Class IIa, IIb and Class III (highest risk), plus Active Implantable Medical Devices (AIMD) and Software as a Medical Device (SaMD). Underwriters use the classification as a starting point for pricing and wording. Class I devices typically sit in mainstream markets at lower limits, while Class III implants and AIMD usually need specialist life sciences markets with broader wordings and higher limits.

Is software as a medical device (SaMD) covered by product liability insurance?

Standard product liability insurance often responds ambiguously to software as a medical device. Purely digital products, AI-driven clinical decision support and diagnostic software sit awkwardly between product liability, professional indemnity and technology liability wordings. A properly structured SaMD placement usually combines product liability for the software as a regulated device with technology E&O or professional indemnity for the underlying development work, ideally through a specialist life sciences underwriter.

How much does medical device liability insurance cost in Australia?

Premiums vary widely by TGA classification, annual turnover, distribution footprint, target markets (including the United States), and claims history. For small importers and distributors of Class I and IIa devices, premiums for combined public and product liability often start from a few thousand dollars per year. Class IIb and Class III devices, implantables, active therapeutic devices and SaMD typically sit materially higher. Tank has placed up to $20 million in public and product liability for life sciences businesses through specialist underwriters.

This is general information only and does not take into account your objectives, financial situation, or needs. You should consider whether the information is appropriate for you and read the relevant Product Disclosure Statement (PDS) before making any decisions about insurance products.

Feedback

Was this helpful?